SAN DIEGO, Sept. 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA - News) announced today that the company will be presenting at two upcoming investor conferences during which it is scheduled to provide a corporate overview of the company and its clinical development and discovery programs. The conference information is as follows:
